US Patent 11787803 Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors
Patent 11787803 was granted and assigned to FORMA Therapeutics on October, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 10, 2022
Date of Patent
October 17, 2023
Patent Applicant
Patent Application Number
17669135
Patent Citations
Patent Inventor Names
Anna Ericsson
Shawn E. R. Schiller
Hongbin Li
Angela V. West
Torsten Herbertz
Jennifer R. Downing
Steven Mischke
Bradford Graves
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11787803 Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
